How much revenue does Masimo make?

Masimo reported $1.53 billion in revenue for fiscal year 2026, down 27.1% from $2.09 billion in fiscal year 2024. In Q1 2027 revenue was $403.60 million.

What is Masimo's largest business segment?

Healthcare, with $1.52 billion or 100% of segment revenue in fiscal year 2025. Next: Other (under 1%).

Where does Masimo make most of its revenue?

United States: 63% of revenue by region in fiscal year 2025, followed by Europe, Middle East and Africa (26%).

What companies are similar to Masimo?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS), Kubota Pharmaceutical Holdings Co., Ltd. (4596.T), Glaukos Corporation (GKOS), Autek China Inc. (300595.SZ).

Masimo Corporation (MASI) Stock

Executive TeamFinancialsSegmentsShareholders

About Masimo Corporation

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET plat...

At a glance

Masimo reported revenue of $1.53 billion for fiscal year 2026, down 27.1% from fiscal year 2024, and net income of -$151.50 million. In Q1 2027 (the quarter ended March 31, 2026) revenue was $403.60 million. Its largest business segment, Healthcare, brought in 100% of segment revenue in fiscal year 2025; United States was the largest region with 63%.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.